AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Autophagy/Apoptosis Balance in Placental Vascular Pathologies

Recruitingn/aAges 18 Years - anyFemaleCentre Hospitalier Universitaire de Nฤซmes
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Pregnancy increases the risk of thrombosis. Placenta-mediated diseases are a risk factor for cardiovascular pathologies and can lead to maternal-fetal morbidity and mortality. It is essential to understand the cellular and molecular mechanisms of dysfunctions at the vascular-placental interface so that systemic vascular risk can be characterized and, ultimately, screened for, on the basis of new markers (targeted preventive management). Deregulated autophagy could be the starting point for cell death by apoptosis or necrosis leading to complications. The pathophysiological mechanisms involved in trophoblast apoptosis are incompletely described. This project follows on from the GrossAuTop-1 study, which investigated the intra- and inter-individual variability of autophagy and apoptosis activities in women during pregnancy. The aim of this project is to study autophagy and apoptosis acti

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Pregnant women developing a placental vascular complication (preeclampsia and/or intrauterine growth retardation), hospitalized and delivering at Nimes University Hospital. * Pregnant woman with free and informed consent. * Pregnant woman affiliated with and/or benefiting from a health insurance scheme. Exclusion criteria: * Multiple pregnancy. * Presence of hypertension and/or proteinuria prior to pregnancy. * Participant in an interventional drug study. * Persons in a period of exclusion determined by another study. * Persons under court protection, guardianship or curatorship. * Persons unable to give consent. * Persons for whom it is impossible to give informed information.
๐Ÿ’Š

What it tests

  • Blood test
  • Urine test
๐Ÿ“

Where

1 site
Nimes University Hospital
Nรฎmes, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy